Potential Role of Helicobacter pylori Infection in Hepatocellular Carcinoma: A Clinical and Laboratory-Based Study
Moazzam Hossian 1, Md. Mahmudul Hasan2, Afrin Sultana 3, Shib Shankar Das 4 , Pravas Paul5, Md Shamsuzzaman6, Md. Moshiur Rahman7, Md. Khaja Mohi Uddin8, Md. Abu Sayem 9, Md Samiul Bashir 10*
Integrative Biomedical Research (Former Journal of Angiotherapy) 8(12) 1-9 https://doi.org/10.25163/angiotherapy.81210217
Submitted: 09 October 2024 Revised: 03 December 2024 Published: 06 December 2024
Abstract
Background: Helicobacter pylori (H. pylori) infection has been a pertinent global health concern with possible extra pulmonary related problems including liver concerns. This research required to determine the prevalence of H. pylori infections and its relationship with liver fibrosis and cirrhosis among patients attending the hospital while accounting a range of relevant demographics and clinical factors. Methodology: The total population sample in this study was 215, enrolled as participants for a cross-sectional observational study. Evaluation of H. pylori was conducted through serological and Chemiluminescence Immunoassay (CLIA) techniques. Other parameters that needed to be noted included demographic information, co-existing health disorders, lifestyle habits such as smoking or drinking alcohol, and biochemical indicators of liver health like ALT, AST, ALP, bilirubin, albumin etc. For comparative analysis between the populations, frequency distribution was done and later a comparative assessment through P-value relational definitional assessment for significant associations was computed. Results: The respondents were 51.6% women, and mostly in the 26-45 age bracket. H. Pylori contamination was revealed in 67.5% of the cases with 43.26% positive by Chemiluminescence Immunoassay (CLIA) and 24.19% by serology. Considerable associations were noted with H. Pylori for infection and elevated hepatic transaminases ALT, AST and ALP, and increased bilirubin levels (p < 0.05). Conclusion: It does appear from these results that H. Pylori infection has a considerable association with liver fibrosis or cirrhosis, demonstrating a need to control H. Pylori infection among patients with chronic liver disease or those who are prone to this disease.
Keywords: Helicobacter pylori, Hepatocellular carcinoma, Liver fibrosis, Cirrhosis, Liver function.
References
Abadi, A. T. B. (2017). Strategies used byhelicobacter pylorito establish persistent infection. World Journal of Gastroenterology, 23(16), 2870. https://doi.org/10.3748/wjg.v23.i16.2870
Amieva, M. R., & El–Omar, E. M. (2008). Host-Bacterial Interactions in Helicobacter pylori Infection. Gastroenterology, 134(1), 306–323. https://doi.org/10.1053/j.gastro.2007.11.009
Belete, M. W., Kebede, M. A., Bedane, M. R., Berhe, T. T., Tekle, A. B., Shash, E. P., Eshetu, M. A., Bushiso, G. D., & Loge, B. Y. (2024). Factors associated with severity and length of hospital stay in patients with acute upper gastrointestinal bleeding: insights from two Ethiopian hospitals. International Journal of Emergency Medicine, 17(1). https://doi.org/10.1186/s12245-024-00768-1
Czaja, A. J. (2014). Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World Journal of Gastroenterology, 20(10), 2515. https://doi.org/10.3748/wjg.v20.i10.2515
D’souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020). Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology, 26(38), 5759–5783. https://doi.org/10.3748/wjg.v26.i38.5759
Dinca, A. L., Meli?, L. E., & Marginean, C. O. (2022). Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer. Children, 9(7), 1083. https://doi.org/10.3390/children9071083
Feng, H., Zhou, X., & Zhang, G. (2014). Association between cirrhosis and Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology, 26(12), 1309–1319. https://doi.org/10.1097/meg.0000000000000220
Ferenci, P., Fried, M., Labrecque, D., Bruix, J., Sherman, M., Omata, M., Heathcote, J., Piratsivuth, T., Kew, M., Otegbayo, J. A., Zheng, S., Sarin, S., Hamid, S. S., Modawi, S. B., Fleig, W., Fedail, S., Thomson, A., Khan, A., Malfertheiner, P., . . . Mair, A. L. (2010). Hepatocellular carcinoma (HCC). Journal of Clinical Gastroenterology, 44(4), 239–245. https://doi.org/10.1097/mcg.0b013e3181d46ef2
Hellgren, U., & Julander, I. (1986). Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis?. Scandinavian journal of infectious diseases, 18(5), 487-488.
Huang, M., Chen, H., Wang, H., Wang, X., Wang, D., Li, Y., Zhou, Q., Zhang, D., Li, M., & Ma, L. (2024). Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: An analysis of the Global Burden of Disease Study. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-4099455/v1
Kim, J. W., Kim, T. J., Kim, J. E., Na, J. E., Lee, H., Min, B., Lee, J. H., Rhee, P., & Kim, J. J. (2022). Impact of Helicobacter pylori Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 22(2), 131–138. https://doi.org/10.7704/kjhugr.2021.0060
Kim, T. J., Sinn, D. H., Min, Y. W., Son, H. J., Kim, J. J., Chang, Y., Baek, S., Ahn, S. H., Lee, H., & Ryu, S. (2017). A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. Journal of Gastroenterology, 52(11), 1201–1210. https://doi.org/10.1007/s00535-017-1337-y
Kumar, S., Patel, G. K., & Ghoshal, U. C. (2021). Helicobacter Pylori-Induced inflammation: Possible factors modulating the risk of gastric cancer. Pathogens, 10(9), 1099. https://doi.org/10.3390/pathogens10091099
Lala, V., Zubair, M., & Minter, D. (2023, July 30). Liver function tests. Treatment & Management | Point of Care. https://www.statpearls.com/point-of-care/20995/
Lodato, F. (2006). Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World Journal of Gastroenterology, 12(45), 7239. https://doi.org/10.3748/wjg.v12.i45.7239
Mak, D., & Kramvis, A. (2021). Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa. Hepatoma Research. https://doi.org/10.20517/2394-5079.2021.15
Mantovani, A., Lando, M. G., Borella, N., Scoccia, E., Pecoraro, B., Gobbi, F., Bisoffi, Z., Valenti, L., Tilg, H., Byrne, C. D., & Targher, G. (2024). Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis. Liver International, 44(7), 1513–1525. https://doi.org/10.1111/liv.15925
Mantovani, A., Turino, T., Altomari, A., Lonardo, A., Zoppini, G., Valenti, L., Tilg, H., Byrne, C. D., & Targher, G. (2019). Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism, 96, 56–65. https://doi.org/10.1016/j.metabol.2019.04.012
Mohammadi, M., Attar, A., Mohammadbeigi, M., Peymani, A., Bolori, S., & Fardsanei, F. (2023). The possible role of Helicobacter pylori in liver diseases. Archives of Microbiology, 205(8). https://doi.org/10.1007/s00203-023-03602-z
Naito, Y., & Yoshikawa, T. (2002). Molecular and cellular mechanisms involved in Helicobacter pylori -induced inflammation and oxidative stress 1,2 1Guest Editor: Giuseppe Poli 2This article is part of a series of reviews on “Reactive Oxygen and Nitrogen in Inflammation.” The full list of papers may be found on the homepage of the journal. Free Radical Biology and Medicine, 33(3), 323–336. https://doi.org/10.1016/s0891-5849(02)00868-7
Okushin, K., Tsutsumi, T., Ikeuchi, K., Kado, A., Enooku, K., Fujinaga, H., Moriya, K., Yotsuyanagi, H., & Koike, K. (2018). Helicobacter pyloriinfection and liver diseases: Epidemiology and insights into pathogenesis. World Journal of Gastroenterology, 24(32), 3617–3625. https://doi.org/10.3748/wjg.v24.i32.3617
Prudente, T. P., Mezaiko, E., Oliva, H. N. P., Yamamoto-Silva, F. P., De Freitas Silva, B. S., Oliva, I. O., & Risch, H. (2025). Associations between colonization with Helicobacter pylori and risk of gastrointestinal tract cancers: An umbrella review of meta-analyses. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14394
Rabelo-Gonçalves, E. M. (2015). Extragastric manifestations ofHelicobacter pyloriinfection: Possible role of bacterium in liver and pancreas diseases. World Journal of Hepatology, 7(30), 2968. https://doi.org/10.4254/wjh.v7.i30.2968
Rana, M. S., Bashir, M. S., Das, S. S., Hossain, M., & Barua, S. (2024). Biomarkers for hepatocellular carcinoma: Diagnosis, prognosis, and treatment response assessment – A systematic review. Journal of Primeasia, 5(1), 1–8. https://doi.org/10.25163/primeasia.519784
Rees, K. R., & Sinha, K. P. (1960). Blood enzymes in liver injury. The Journal of Pathology, 80(2), 297–307. https://doi.org/10.1002/path.1700800213
Salam, M. T., Mou, M. A., et al. (2024). Assessment of lipid profile in hepatocellular carcinoma patients: A prospective study in Bangladesh. Journal of Primeasia, 5(1), 1–8. https://doi.org/10.25163/primeasia.519787
Shin, W. S., Xie, F., Chen, B., Yu, J., Lo, K. W., Tse, G. M. K., To, K. F., & Kang, W. (2023). Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers, 15(20), 4993. https://doi.org/10.3390/cancers15204993
Singh, A., Hussain, S., & Antony, B. (2021). Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 15(3), 813–822. https://doi.org/10.1016/j.dsx.2021.03.019
T. Akter, M. R. Ali, M. N. A. Faruquee, M. S. Bashir, S. Rahaman, M. A. Rahman, S. Islam. A Comprehensive Study of Hepatitis B Infections in Bangladesh: Epidemiology, Risk Factors and Clinical-Laboratory Correlations. Viral Infections and Cancer Research. 2024; 1(1): 8426.doi:10.59429/vicr.v1i1.8426
Thrift, A. P., El-Serag, H. B., & Kanwal, F. (2016). Global epidemiology and burden of HCV infection and HCV-related disease. Nature Reviews Gastroenterology & Hepatology, 14(2), 122–132. https://doi.org/10.1038/nrgastro.2016.176
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., & Kawashima, T. (1993). Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease. New England Journal of Medicine, 328(25), 1797–1801. https://doi.org/10.1056/nejm199306243282501
Tufael, T., Kar, A., Rashid, M. H. O., Sunny, A. R., Raposo, A., Islam, M. S., Hussain, M. A., Hussen, M. A., Han, H., Coutinho, H. D. M., Ullah, M. S., & Rahman, M. M. (2024). Diagnostic efficacy of tumor markers AFP, CA19-9, and CEA in hepatocellular carcinoma patients. Journal of Angiotherapy, 8(4), 1–10. https://doi.org/10.25163/angiotherapy.849513
Tufael, T., Kar, A., Upadhye, V. J., Dutta, A., Islam, M. R., Sattar, A., Ali, M. E., Akter, J., Bari, K. F., Salam, M. T., Banik, P. C., Khan, M. S. S., & Sunny, A. R. (2024). Significance of serum biomarkers in early diagnosis of hepatocellular carcinoma in patients with Fisher groups. Journal of Angiotherapy, 8(1), 1–9. https://doi.org/10.25163/angiotherapy.819440
Tufael, T., Kar, A., Upadhye, V. J., Dutta, A., Islam, M. R., Sattar, A., Ali, M. E., Akter, J., Bari, K. F., Salam, M. T., Banik, P. C., Khan, M. S. S., & Sunny, A. R. (2024). Significance of serum biomarkers in early diagnosis of hepatocellular carcinoma in patients with Fisher groups. Journal of Angiotherapy, 8(1), 1–9. https://doi.org/10.25163/angiotherapy.819440
Waheed, A., Aboelnasr, M. S., Mourad, H., & Mohamed, W. S. (2024). Helicobacter Pylori Infection, Lipid Profile, and Insulin Resistance in Obese Patients with Non-Alcoholic Fatty Liver Disease. African Journal of Gastroenterology and Hepatology, 7(1), 211–224. https://doi.org/10.21608/ajgh.2024.306471.1057
Waluga, M. (2015). From the stomach to other organs:Helicobacter pyloriand the liver. World Journal of Hepatology, 7(18), 2136. https://doi.org/10.4254/wjh.v7.i18.2136
Zheng, Z., & Wang, B. (2021). The Gut-Liver Axis in Health and Disease: The role of Gut Microbiota-Derived Signals in liver injury and Regeneration. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.775526
View Dimensions
View Altmetric
Save
Citation
View
Share